Mana Baskovic, DO
Obstetrics & Gynecology · Santa Monica
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Baskovic’s office at (310) 828-8585 to ask if they take your plan before you enroll.
California Medical Board record
Licence A15816 · Cancelled
Licence status: Cancelled · since 1954 · Medical College of Pennsylvania.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$2,510
Pharmacies billed $2,510 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 32) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
26 generic and fewer than 11 brand-name prescriptions · $2,510 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 32 | 17 | 0% (0) | None | $2,510 |
| 2023 | 107 | 33 | 0% (0) | 24% | $12,898 |
| 2022 | 82 | 29 | None | 21% | $8,481 |
| 2021 | 64 | 29 | 0% (0) | 23% | $5,668 |
| 2020 | 18 | 12 | 0% (0) | None | $1,564 |
| 2019 | 29 | 19 | 66% (19) | None | $1,759 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Estradiol (Twice Weekly) | 31 | $3,180 | $103 |
| Estradiol | 19 | $2,713 | $143 |
| Progesterone | 16 | $857 | $54 |
2022: 2 drugs
| Estradiol (Twice Weekly) | 21 | $2,315 | $110 |
| Triamterene-Hydrochlorothiazid | 13 | $62 | $5 |
2021: 1 drug
| Estradiol | 16 | $1,954 | $122 |
2019: 1 drug
| Oxycodone | 15 | $93 | $6 |
Money from drug and device companies
$285 in 2024
| 2024 | 4 | 8 | None | $285 |
| 2023 | 8 | 15 | None | $344 |
| 2022 | 9 | 15 | None | $3,265 |
| 2021 | 10 | 24 | None | $445 |
| 2020 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Wegovy | $120 | 1 payment
|
| Pfizer | Myfembree | $98 | 4 payments
|
| Becton Dickinson and | Bd Onclarity | $41 | 2 payments
|
| Astellas Pharma US | Veozah | $26 | 1 payment
|
See all 8 published payments
| Pfizer | Meals · 2024-12-04 | Myfembree | $21 |
| Astellas Pharma US | Meals · 2024-08-07 | Veozah | $26 |
| Pfizer | Meals · 2024-06-12 | Myfembree | $23 |
| Pfizer | Meals · 2024-05-09 | Myfembree | $27 |
| Becton Dickinson and | Meals · 2024-04-08 | Bd Onclarity | $23 |
| Pfizer | Meals · 2024-03-19 | Myfembree | $28 |
| Novo Nordisk | Meals · 2024-02-16 | Wegovy | $120 |
| Becton Dickinson and | Meals · 2024-02-08 | Bd Onclarity | $18 |
See earlier years (2023, 2022, 2021, 2020)
2023: $344
| Sumitomo Pharma America | Myfembree | $79 | 3 payments
|
| Pfizer | Myfembree | $65 | 3 payments
|
| Myriad Women's Health | None | $42 | 1 payment
|
| Hologic Sales and Service | Aptima | $41 | 2 payments
|
| Mayne Pharma Commercial | None | $39 | 2 payments
|
| Becton Dickinson and | Bd Onclarity | $33 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $25 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $20 | 1 payment
|
2022: $3,265
| Intuitive Surgical | Davinci Xi | $3,000 | 1 payment
|
| Myovant Sciences | Myfembree | $87 | 5 payments
|
| Abbvie | Oriahnn | $41 | 2 payments
|
| TherapeuticsMD | Annovera | $36 | 2 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $23 | 1 payment
|
| Hologic | Aptima | $22 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $22 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $19 | 1 payment
|
| Evofem Biosciences | Phexxi | $14 | 1 payment
|
2021: $445
| AbbVie | Lo Loestrin Fe | $193 | 11 payments
|
| Evofem Biosciences | Phexxi | $74 | 4 payments
|
| TherapeuticsMD | Annovera | $36 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $24 | 1 payment
|
| Agile Therapeutics | Twirla | $24 | 1 payment
|
| GlaxoSmithKline | Shingrix | $24 | 1 payment
|
| Myovant Sciences | Myfembree | $23 | 1 payment
|
| Amgen | Evenity | $23 | 1 payment
|
| Applied Medical Resources | None | $12 | 1 payment
|
| Organon | Nexplanon | $11 | 1 payment
|
2020: $23
| AbbVie | Lo Loestrin Fe | $23 | 1 payment
|
Professional record
- NPI
- 1750742698
- Licence
- CA 15816California A15816: Cancelled
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 1301 20th St Ste 270, Santa Monica, CA, 90404
- NPI first listed
- 2016-03-18
- NPI last updated
- 2024-01-09
- NPI record certified
- 2024-01-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Drive, Palo Alto, CA, 94305